2 Pharma Stocks to Target

President Trump has said China tariffs could remain in place for a "substantial period of time"

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Opening View
OPENING VIEW
 
 

3/21/2019

The Search for The Perfect Pot Stock is Over


2019 is off to crazy start for many marijuana stocks, some reaching all-time highs. But at 250 times earnings where is the upside? The key is to play pot stocks like Buffett, find undervalued companies with great long term earning potential, like this gem we've uncovered.

 unit
Dow Futures Down Triple Digits on Fed, Trade Woes

By Patrick Martin
Share On

Dow Jones Industrial Average (DJI) futures are pointed sharply lower this morning, after Wednesday's Fed announcement sparked concern over a slowing global economy. U.S.-China trade uncertainty is also keeping markets on edge, after President Donald Trump said yesterday tariffs on Chinese goods could remain in place for a "substantial period of time." Elsewhere, oil prices are booming, with April-dated crude futures up 1.9% at $60.12 per barrel. 

Continue reading for more on today's market, including: 

  • 2 pharma stocks flashing buy.
  • Short seller: This stock is "running on fumes."
  • This biotech stock just won its 10th straight.
  • Plus, another bull note for Apple; Micron hot after earnings beat; and Biogen sinks after pulling Alzheimer's drug.
>> Continue reading...
LATEST HEADLINES
>> Analyst Spots Buying Opportunity After Stock's "Puzzling" Sell-Off
Yesterday was SCS' worst day in more than 3 years
>> Dow Drops Triple Digits After Fed
The central bank expects no more rate hikes in 2019
>> Analyst Note Attracts SOLO Call Buyers
Benchmark initiated coverage with a "speculative buy" rating
>> 2 Pharma Stocks Flashing Buy
Both equities sport attractively priced short-term options
>> Analysts Cheer Pharma Stock's New CEO
CYTK has roughly doubled in the past two weeks
ADVERTISEMENT

One Pot Stock Set to Dominate


Marijuana has become an all-out race to profitability, many are light years away, but a select few have spent years building and acquiring, most of the names you know. It's the name you likely don't know that could yield life changing returns, and you can get that name here.

To ensure delivery of Schaeffer's Opening View, add us to your contacts! For more information, please visit this link for further instructions.

This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Opening View or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Opening View? You can unsubscribe here.

For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions.

Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
Schaeffer's Opening View
SCHAEFFER'S OPENING VIEW
Posted by: at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)